Fri, Sep 24, 2:15 PM - 3:30 PM
Virtual
Evaluating the Use of Registries for Assessing Safety in Pre-Market Applications
Panel Discussion (303547)
*
Brenda Crowe, Eli Lilly
*
Margaret Gamalo, Pfizer Inc.
*
Clara Y Kim, US Food and Drug Administration
*
Marc Stone, FDA/CDER
*
William Wang, Merck & Co., Inc.
